MeMed services

We have been collaborating with leading clinicians, scientists and commercial partners around the globe to develop and validate a proprietary set of rapid blood tests with the aim of empowering physicians to tackle some of the most challenging clinical dilemmas. These tests build on an exquisitely informative system – the human immune system. Using low and high-throughput molecular measurements, the application of bioinformatics and machine learning approaches, we`ve identified biomarkers that are key players in the body`s response to different disease states. These biomarkers and algorithms are now being integrated into immunological fingerprints for decoding multiple disease states.

Sepsis is the body’s overwhelming and life-threatening response to infection that can lead to tissue damage, organ failure, and death.  Common signs and symptoms include fever, increased heart rate, increased breathing rate, and confusion. Sepsis has been named as the most expensive in-patient cost in American hospitals in 2014 at nearly $27 billion each year. Forty percent of patients diagnosed with severe sepsis do not survive. Up to 50% of survivors suffer from post-sepsis syndrome.